Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

NCT02256982 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02256982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02256982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2014
Completion date
March 31, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable intrahepatic cholangiocarcinoma, unresectable intrahepatic cholangiocarcinoma